Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better?

Gomberg-Maitland M.

Source: Eur Respir J 2006 Oct 01;28(4):683-686

Journal Issue: October

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gomberg-Maitland M.. Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better?. Eur Respir J 2006 Oct 01;28(4):683-686

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014
Chronic post-embolic pulmonary hypertension: a new target for medical therapies?}, Source: Eur Respir Rev 2013; 22: 258-264 Year: 2013
Seeking the right targets: gene therapy advances in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 235-237 Year: 2012
Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015
Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020
Pulmonary arterial hypertension: bridging the present to the future Source: Eur Respir Rev 2012 21: 267-270 Year: 2012
Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007
Novel therapeutic perspectives in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 193-194 Year: 2003
Pulmonary arterial hypertension: tailoring treatment to risk in the current era Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017 Year: 2017
Upfront triple therapy for pulmonary arterial hypertension: is three a crowd or critical mass? Source: Eur Respir J 2014; 43: 1556-1559 Year: 2014
Challenging the concept of adding more drugs in pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017 Year: 2017
“Rehab for all!” Is it too early in pulmonary arterial hypertension? Source: Eur Respir J, 54 (5) 1901558; 10.1183/13993003.01558-2019 Year: 2019
Pulmonary arterial hypertension: treatment options Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED Year: 2018
What do we learn from novel genes in pulmonary hypertension? Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life Year: 2020
?-blockers in pulmonary arterial hypertension: generation might matter Source: Eur Respir J 2016; 47: 682-684 Year: 2016
Pulmonary arterial hypertension: combination therapy in the modern management era Source: Eur Respir Rev 2010 19: 348-349 Year: 2010
Optimal management of severe pulmonary arterial hypertension Source: Eur Respir Rev 2011; 20: 254-261 Year: 2011
Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018